Home › Meningioma › Maryland
Meningioma clinical trials in Maryland
5 studies for Meningioma are looking for participants at sites in Maryland.
Cities in Maryland
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014Natural History Study of Patients With Neurofibromatosis Type 2
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 8 to 75 · All sexes · Updated Oct 2, 2026 · NCT00598351Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 2, 2026 · NCT04374305Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Johns Hopkins, Baltimore
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated May 14, 2026 · NCT05636618Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
- National Institutes of Health, Bethesda
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT04541082From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.